SlideShare a Scribd company logo
S L I D E 0
Nephrotoxins and drug interactions
Ibrahim Sandokji
S L I D E 1
15 y/o male presents with back pain and malaise. He took
ibuprofen and naproxen last week. No fever. Normal urine
output. Normal BPs. No edema. Serum creatinine 3.6
mg/dL.
The most likely finding on urinalysis would be:
a) 1+ heme, 1+ LE, >100 WBC/hpf
b) Bland urine with trace protein
c) Dysmorphic RBCs, RBC casts, heavy protein
d) Muddy brown casts, debris
S L I D E 2
ABP Content Specifications
• Nephrotoxins and drug interactions:
– Know common nephrotoxins, their mechanisms of
nephrotoxicity, and their clinical manifestations
– Know the natural history of kidney injury caused by
common nephrotoxins
– Recognize drugs that potentiate nephrotoxicity
– Know the management of different types of
nephrotoxicity
• Nephrotoxic Injury Negated by Just-in-time Action (NINJA)
S L I D E 3
Kidney Vulnerability
• Final pathways for xenobiotics excretion (particularly, hydrophilic
drugs)
• Proximal tubular cells possess specific secretory pathways -> high
concentrations during transcellular transport -> cytotoxicity
• Large amount of energy consumption. Alterations of blood supply -
> profound cellular damage
• Large amount of oxygen requirement -> high susceptibility to
oxidative stress
• Several medications alter renal hemodynamics -> ischemic damage
• Some drugs are highly concentrated in the tubular lumen and can
crystallize -> obstructive nephropathy
S L I D E 4
Natural History of Nephrotoxic-induced AKI
• Usually non-oliguric AKI
• Typically dose-dependent (except AIN which is
idiosyncratic) and more likely to occur with
nephrotoxin combinations
• Urinalysis is often bland
• Might see WBCs & possibly eosinophils in the
urine
• Recovery after removing offending agent(s)
S L I D E 5
S L I D E 6
Acyclovir
• Nephrotoxicity can be seen in 17–35% of children receiving IV
acyclovir. (Rao 2015)
Mechanism of toxicity:
• Rapidly excreted in the urine (both filtered and secreted)
• Crystallization in tubular lumen -> obstructive nephropathy
• Direct tubular toxicity
• Transported by shared organic acid transporters with certain beta-
lactam antibiotics (particularly ceftriaxone) -> increase
nephrotoxicity risk
S L I D E 7
Acyclovir
• Prevention of nephrotoxicity:
– Optimize hydration
– Administer over 1–2 hours
– Adjust dose if decreased renal function
– Avoid concurrent nephrotoxic medication exposure
S L I D E 8
Amphotericin B
• AKI occurs in 49–65% of adult receiving amphotericin B
Mechanism of toxicity:
• Direct distal tubular toxicity: affect ergosterol in the epithelial cell
membrane -> forms pores in the epithelial cell membrane
• Renal vasoconstriction
• Increased tubular membrane permeability lead to hypokalemia,
hyponatremia, acidosis & hypomagnesemia
• Risk factors:
– Cumulative dose
– Treatment duration
– Dosing schedule
– Dehydration
– Concomitant diuretics or other nephrotoxic drugs
– Impaired glomerular filtration at baseline
S L I D E 9
Amphotericin B
• Lipid formulations of amphotericin B (liposomal, lipid complex,
colloidal dispersion):
• A European multicenter prospective open-label study with 134
adults and 204 children with fever and neutropenia compared the
use of liposomal and conventional amphotericin B:
– Similar efficacy, defined as resolution of fever in 3 consecutive days &
recovery of neutrophils
– Nephrotoxicity (doubling of baseline creatinine) occurred in 3% of
liposomal amphotericin, compared to 23% of conventional
amphotericin B group (P<0.01)
– Time to develop nephrotoxicity was longer in liposomal amphotericin
than amphotericin B (P<0.01) and severe hypokalaemia was observed
less frequently in liposomal amphotericin (P<0.01)
Prentice 1997
S L I D E 10
Aminoglycosides
Mechanism of toxicity:
• In the kidney, aminoglycosides exclusively accumulate in proximal
tubular cells via endocytic pathways -> transported to the
endosomal compartment -> accumulates in the lysosomes ->
secretory pathway to the Golgi apparatus and ER
• ER stress: disruption of normal protein folding -> accumulation of
misfolded and unfolded proteins induces their aggregation and
subsequent cytotoxicity -> acute tubular necrosis
• Destabilize intracellular membranes -> redistribution of the drug
throughout the cytosol -> acts on the mitochondria -> induce
apoptosis
• In the lysosomes, aminoglycosides bind to phospholipids ->
inhibition of phospholipase activity -> phospholipid accumulation -
> tubular cell death
S L I D E 11
Aminoglycosides
• Factors associated with increased risk of nephrotoxicity:
– Drug dosage
– Duration of administration
– Dosing interval
– Preexisting renal disease
– Dehydration
– Hepatic dysfunction
– Sepsis
– Concomitant nephrotoxic and diuretic drugs Patzer (2008)
• Cochrane review of 13 RCT showed:
• Once- and three-times-daily equally effective in CF pulmonary
exacerbations
• The percentage change in creatinine significantly favoured once-
daily treatment in children, MD -8.20 (95% CI -15.32 to -1.08), but
showed no difference in adults, MD 3.25 (95% CI -1.82 to 8.33).
Smyth AR (2010)
S L I D E 12
Vancomycin
• Nephrotoxicity occurs in 12–43% of adults treated with
vancomycin. (Rybak 2009)
Mechanism of toxicity:
• Proximal renal tubular cells are the main nephron segment
impaired by vancomycin
• Energy-dependent transport of vancomycin from the blood to the
proximal tubular cells across the basolateral membrane
• Exposure to high doses over long time -> oxidative stress and
mitochondrial damage
S L I D E 13
Vancomycin
• Factors associated with increased risk of nephrotoxicity:
– Drug dosage
– Duration of administration
– Preexisting renal disease Patzer (2008)
– Critical illness
– Concomitant nephrotoxic
• A retrospective chart review in NICU
• AKI occurred in 2.7% of patients
(increase in SCr of at least 0.5 mg/L
or an increase of at least 100% from
lowest trough previously available)
Bhargava (2017)
Fit plot between vancomycin trough concentrations and post vancomycin creatinine.
The plot depicts a positive co-relation between the two parameters
S L I D E 14
Calcineurin Inhibitor (Cyclosporin A)
• Acute toxicity (reversible):
– Afferent arteriolar vasospasm
– Renal hypoperfusion and decreased GFR
– Reversible with decrease the dose or discontinuation
• Tubular toxic effects:
Renal cell apoptotic mechanisms of CyA-induced
S L I D E 15
Calcineurin Inhibitor (Cyclosporin A)
• CNI Nephropathy:
– Proximal tubular injury -> tubular atrophy
– Diffuse interstitial fibrosis or striped interstitial fibrosis
– Arteriopathy: constrictive proliferation with mucoid thickening
and arterial hyalinosis
S L I D E 16
CNI Nephropathy
(a) proximal tubular epithelial cell showing the fine isometric vacuoles; (b) typical striped fibrosis pattern (c) an afferent
arteriole showing the characteristic nodular hyaline arteriosclerosis; (d) similar nodule in a non-afferent arteriole
S L I D E 17
Calcineurin Inhibitor
• Tacrolimus
– Similar side effect profile
– Less cosmetic effects
• Gingival hyperplasia
• Hirsutism
– Less hyperlipidemia
• In a Prospective study of 41 patients divided
• Hirsutismus and gingival hyperplasia were seen in 10%, and 15% of
CsA group, while it wasn’t observed at all in the Tac group
• No difference in nephrotoxicity or hepatotoxicity
(Ozan 2013)
S L I D E 18
NSAIDs
S L I D E 19
NSAIDs
Medical Pharmacology, TMWeb, Tulane University
S L I D E 20
NSAIDs
• Case series of 7 children aged 13–17.5 years developed AKI after
treatment with various NSAIDs
– (6/7) used more than one kind of NSAID
– 1 to 4 days between NSAID use and symptoms
– Flank pain (4/7), abdominal pain (3/7), and vomiting (3/7)
– All patients had nonoliguric AKI
– Microscopic hematuria and proteinuria (5/7) patients
– Biopsy done in three patients:
• Mild interstitial inflammation in one patient
• Normal in two patients
– All patients were treated with intravenous fluids
• One patient received corticosteroids
– Renal function was completely normalized in all patients within 7–16
days
Krause 2005
S L I D E 21
Acute Interstitial Nephritis
• Usually present with rise in sCr and non-specific symptoms
• Nausea, vomiting, malaise, back/flank pain, or asymptomatic
• Allergic-type symptoms like fevers, rash, peripheral eosinophilia
• UA: WBC casts, hematuria, mild proteinuria, or bland urine
• Non-Oliguria AKI, tubular dysfunction and even Fanconi syndrome
• Treatment:
– Discontinuation of offending agent
– Rarely might need a biopsy if:
• Unclear diagnosis
• When considering steroid therapy
• Or, if started steroids but no response in one week
S L I D E 22
Singh AK, Colvin RB. N Engl J Med 2003;349:2055-2063.
Acute Interstitial Nephritis
S L I D E 23
White Blood Cell Casts Red Blood Cell Casts
Hyaline Casts Muddy Brown Granular Casts
Waxy Casts
Fatty Casts
S L I D E 24
Low power view of severe acute interstitial nephritis
showing diffuse interstitial inflammatory infiltrate
Inflammatory process predominantly in the interstitium.
Insert shows a higher magnification, with arrows
pointing to eosinophils in the interstitium
S L I D E 25
Nephrotoxic Injury Negated by Just-in-time Action (NINJA)
• Automated system using EHR data in patients with 3+ nephrotoxic
medications or 3+ days of IV aminoglycoside exposure
S L I D E 26
• 1,749 patients with 2,358 admissions were included. 575 individual
AKI episodes were observed (47% stage 1, 33% stage 2, and 20%
stage 3)
• Nephrotoxic medication exposure rate decreased by 38% (from
11.63 to 7.24 patients/1000 patient days)
Nephrotoxic Injury Negated by Just-in-time Action (NINJA)
S L I D E 27
• AKI rates decreased by 64% (from 2.96 to 1.06 patients with
AKI/1000 patient days) during the study period.
Nephrotoxic Injury Negated by Just-in-time Action (NINJA)
S L I D E 28
15 y/o male presents with back pain and malaise. He took
ibuprofen and naproxen last week. No fever. Normal urine
output. Normal BPs. No edema. Serum creatinine 3.6
mg/dL.
The most likely finding on urinalysis would be:
a) 1+ heme, 1+ LE, >100 WBC/hpf
b) Bland urine with trace protein
c) Dysmorphic RBCs, RBC casts, heavy protein
d) Muddy brown casts, debris
S L I D E 29
Summary
S L I D E 30
References
• Avner, et al. Pediatric Nephrology. 2016
• Bhargava, et al. The association between vancomycin trough concentrations and acute kidney injury in
the neonatal intensive care unit. BMC Pediatr. 2017 Feb 11;17(1):50.
• Ekmekçioğlu, et al. Comparison of tacrolimus with a cyclosporine microemulsion for
immunosuppressive therapy in kidney transplantation. Turkish journal of urology. 2013;39(1):16-21.
• Goldstein SL, Mottes T, Simpson K, Barclay C, Muething S, Haslam DB, Kirkendall ES. A sustained
quality improvement program reduces nephrotoxic medication-associated acute kidney injury. Kidney
Int. 2016 Jul;90(1):212-21
• Krause, et al. Acute renal failure, associated with non-steroidal anti-inflammatory drugs in healthy
children. Pediatr Nephrol. 2005 Sep;20(9):1295-8.
• Patzer L. Nephrotoxicity as a cause of acute kidney injury in children. Pediatr Nephrol.
2008;23(12):2159–73.
• Prentice, et al. A randomized comparison of liposomal versus conventional amphotericin B for the
treatment of pyrexia of unknown origin in neutropenic patients. Br J Haematol. 1997;98: 711–718
• Rao, et al. Intravenous acyclovir and renal dysfunction in children: a matched case control study. J
Pediatr. 2015 Jun;166(6):1462-8.
• Rybak, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the
American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the
Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2009;66(1):82–98.
• Smyth, et al. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic
fibrosis. Cochrane Database Syst Rev. 2014;2.
• Uijtendaal, et al. Once-daily versus multiple-daily gentamicin in infants and children. Ther Drug Monit.
2001;23 (5):506–13.
• Vandecasteele, et al. Recent changes in vancomycin use in renal failure. Kidney Int. 2010;77(9):760–4.
S L I D E 31
Extra Slides
S L I D E 32
Classification of nephrotoxic medications
Pathophysiology Drugs known to cause acute kidney injury
Prerenal
NSAIDs, ACE inhibitors, cyclosporine A (CyA), norepinephrine, AT2-
receptor antagonists, diuretics, interleukins, cocaine, mitomycin C,
tacrolimus, estrogen, quinine
Acute tubular
necrosis
Antibiotics: aminoglycosides, cephalosporins, amphotericin B,
rifampicin, vancomycin, foscarnet, pentamidine
NSAIDs, glaphenin, contrast media, acetaminophen, CyA, cisplatinum,
immunoglobulin, dextran, maltose, sucrose, mannitol, heavy metals
Acute interstitial
nephritis
Antibiotics: ciprofloxacin, methicillin, penicillin G, ampicillin,
cephalosporins, oxacillin, rifampicin
NSAIDs, glaphenin, acetylsalicylic acid (ASA), fenoprofen, naproxen,
phenylbutazone, piroxicam, tolmetin, zomepirac, contrast media,
sulfonamides, thiazides, phenytoin, furosemide, allopurinol,
cimetidine, omeprazole, phenindione
Tubular
obstruction
Sulfonamides, methotrexate, methoxyflurane, glaphenin, triamterene,
acyclovir, ethylene glycol, protease inhibitors
Hypersensitivity
angiitis
Penicillin G, ampicillin, sulfonamides
Thrombotic
microangiopathy
Mitomycin C, CyA, oral contraceptives

More Related Content

Similar to Nephrotoxins.pptx

RPGN in Children.pptx
RPGN in Children.pptxRPGN in Children.pptx
RPGN in Children.pptx
Ibrahim Sandokji
 
AKI - Basics
AKI - BasicsAKI - Basics
AKI - Basics
Naveen Kumar
 
AKI IN ICU.pptx
AKI IN ICU.pptxAKI IN ICU.pptx
AKI IN ICU.pptx
Harsh shaH
 
Aki
AkiAki
Drug induced nephritis
Drug induced nephritis Drug induced nephritis
Drug induced nephritis
Joseph Openy
 
HSP nephritis
HSP nephritisHSP nephritis
HSP nephritis
SUMIT ACHARYA
 
Lupus Nephritis-Diagnosis and management
Lupus Nephritis-Diagnosis and managementLupus Nephritis-Diagnosis and management
Lupus Nephritis-Diagnosis and management
ChibuezeNnonyelu1
 
Contrast induced AKI
Contrast induced AKIContrast induced AKI
Contrast induced AKI
Amit Gulati
 
Pediatric renal transplantation
Pediatric renal transplantationPediatric renal transplantation
Pediatric renal transplantation
ahmed eshiba
 
Ace-I and Contrast induced nehropathy
Ace-I and Contrast induced nehropathyAce-I and Contrast induced nehropathy
Ace-I and Contrast induced nehropathy
Ahad Lodhi
 
Enteric fever
Enteric feverEnteric fever
Enteric fever
Mohammad Omar Ansari
 
Nephrotic-Syndrome-in-Children-Dr.-Bashir-Admani.pdf
Nephrotic-Syndrome-in-Children-Dr.-Bashir-Admani.pdfNephrotic-Syndrome-in-Children-Dr.-Bashir-Admani.pdf
Nephrotic-Syndrome-in-Children-Dr.-Bashir-Admani.pdf
HarmonyOyiko
 
Antimicrobial induced renal failure - shaista sumayya. drug induced renal fai...
Antimicrobial induced renal failure - shaista sumayya. drug induced renal fai...Antimicrobial induced renal failure - shaista sumayya. drug induced renal fai...
Antimicrobial induced renal failure - shaista sumayya. drug induced renal fai...
shaistasumayya2
 
Lupus nephritis nids
Lupus nephritis nidsLupus nephritis nids
Lupus nephritis nids
Nidhil Narayanan
 
Renal involvement with infective endocarditis
Renal involvement with infective endocarditisRenal involvement with infective endocarditis
Renal involvement with infective endocarditis
zizon1985
 
Nephrotic syndrome (1)
Nephrotic syndrome (1)Nephrotic syndrome (1)
Nephrotic syndrome (1)
vaibhavgode
 
Renal disorders.ppt
Renal disorders.pptRenal disorders.ppt
Renal disorders.ppt
HumaQayuum
 
ANTIMICROBIAL INDUCED RENAL FAILURE.pptx
ANTIMICROBIAL INDUCED RENAL FAILURE.pptxANTIMICROBIAL INDUCED RENAL FAILURE.pptx
ANTIMICROBIAL INDUCED RENAL FAILURE.pptx
ShaistaSumayya
 
sepsis.pptx
sepsis.pptxsepsis.pptx
sepsis.pptx
shinyiing1
 

Similar to Nephrotoxins.pptx (20)

RPGN in Children.pptx
RPGN in Children.pptxRPGN in Children.pptx
RPGN in Children.pptx
 
AKI - Basics
AKI - BasicsAKI - Basics
AKI - Basics
 
AKI IN ICU.pptx
AKI IN ICU.pptxAKI IN ICU.pptx
AKI IN ICU.pptx
 
Aki
AkiAki
Aki
 
Drug induced nephritis
Drug induced nephritis Drug induced nephritis
Drug induced nephritis
 
HSP nephritis
HSP nephritisHSP nephritis
HSP nephritis
 
Lupus Nephritis-Diagnosis and management
Lupus Nephritis-Diagnosis and managementLupus Nephritis-Diagnosis and management
Lupus Nephritis-Diagnosis and management
 
Contrast induced AKI
Contrast induced AKIContrast induced AKI
Contrast induced AKI
 
Pediatric renal transplantation
Pediatric renal transplantationPediatric renal transplantation
Pediatric renal transplantation
 
Ace-I and Contrast induced nehropathy
Ace-I and Contrast induced nehropathyAce-I and Contrast induced nehropathy
Ace-I and Contrast induced nehropathy
 
Enteric fever
Enteric feverEnteric fever
Enteric fever
 
Nephrotic-Syndrome-in-Children-Dr.-Bashir-Admani.pdf
Nephrotic-Syndrome-in-Children-Dr.-Bashir-Admani.pdfNephrotic-Syndrome-in-Children-Dr.-Bashir-Admani.pdf
Nephrotic-Syndrome-in-Children-Dr.-Bashir-Admani.pdf
 
Drugs and kidney
Drugs and kidneyDrugs and kidney
Drugs and kidney
 
Antimicrobial induced renal failure - shaista sumayya. drug induced renal fai...
Antimicrobial induced renal failure - shaista sumayya. drug induced renal fai...Antimicrobial induced renal failure - shaista sumayya. drug induced renal fai...
Antimicrobial induced renal failure - shaista sumayya. drug induced renal fai...
 
Lupus nephritis nids
Lupus nephritis nidsLupus nephritis nids
Lupus nephritis nids
 
Renal involvement with infective endocarditis
Renal involvement with infective endocarditisRenal involvement with infective endocarditis
Renal involvement with infective endocarditis
 
Nephrotic syndrome (1)
Nephrotic syndrome (1)Nephrotic syndrome (1)
Nephrotic syndrome (1)
 
Renal disorders.ppt
Renal disorders.pptRenal disorders.ppt
Renal disorders.ppt
 
ANTIMICROBIAL INDUCED RENAL FAILURE.pptx
ANTIMICROBIAL INDUCED RENAL FAILURE.pptxANTIMICROBIAL INDUCED RENAL FAILURE.pptx
ANTIMICROBIAL INDUCED RENAL FAILURE.pptx
 
sepsis.pptx
sepsis.pptxsepsis.pptx
sepsis.pptx
 

More from Ibrahim Sandokji

Journal Club. Joyce Zosyn and AKI in Children JASN 2019.pptx
Journal Club. Joyce Zosyn and AKI in Children JASN 2019.pptxJournal Club. Joyce Zosyn and AKI in Children JASN 2019.pptx
Journal Club. Joyce Zosyn and AKI in Children JASN 2019.pptx
Ibrahim Sandokji
 
Journal Club. Early prediction of pediatric acute kidney injury from the eme...
Journal Club. Early prediction of pediatric acute kidney injury  from the eme...Journal Club. Early prediction of pediatric acute kidney injury  from the eme...
Journal Club. Early prediction of pediatric acute kidney injury from the eme...
Ibrahim Sandokji
 
Journal Club. Native nephrectomy prior to pediatric kidney transplantation: b...
Journal Club. Native nephrectomy prior to pediatric kidney transplantation: b...Journal Club. Native nephrectomy prior to pediatric kidney transplantation: b...
Journal Club. Native nephrectomy prior to pediatric kidney transplantation: b...
Ibrahim Sandokji
 
Journal Club. Recurrence Of Nephrotic Syndrome Following Kidney Transplantat...
Journal Club. Recurrence Of Nephrotic Syndrome Following  Kidney Transplantat...Journal Club. Recurrence Of Nephrotic Syndrome Following  Kidney Transplantat...
Journal Club. Recurrence Of Nephrotic Syndrome Following Kidney Transplantat...
Ibrahim Sandokji
 
Lupus Nephritis - 2021.pptx
Lupus Nephritis - 2021.pptxLupus Nephritis - 2021.pptx
Lupus Nephritis - 2021.pptx
Ibrahim Sandokji
 
Sickle Cell Nephropathy.pptx
Sickle Cell Nephropathy.pptxSickle Cell Nephropathy.pptx
Sickle Cell Nephropathy.pptx
Ibrahim Sandokji
 
Serology in Renal Diseases.pptx
Serology in Renal Diseases.pptxSerology in Renal Diseases.pptx
Serology in Renal Diseases.pptx
Ibrahim Sandokji
 
RTA.pptx
RTA.pptxRTA.pptx
Renal Embryology.pptx
Renal Embryology.pptxRenal Embryology.pptx
Renal Embryology.pptx
Ibrahim Sandokji
 
Potassium Disorders.pptx
Potassium Disorders.pptxPotassium Disorders.pptx
Potassium Disorders.pptx
Ibrahim Sandokji
 
MPGN.pptx
MPGN.pptxMPGN.pptx
MPGN.pptx
Ibrahim Sandokji
 
Membranous.pptx
Membranous.pptxMembranous.pptx
Membranous.pptx
Ibrahim Sandokji
 
2017 AAP HTN Guidelines.pptx
2017 AAP HTN Guidelines.pptx2017 AAP HTN Guidelines.pptx
2017 AAP HTN Guidelines.pptx
Ibrahim Sandokji
 
Cystinosis.pptx
Cystinosis.pptxCystinosis.pptx
Cystinosis.pptx
Ibrahim Sandokji
 
AKI for VIPCo - Sandokji.pptx
AKI for VIPCo - Sandokji.pptxAKI for VIPCo - Sandokji.pptx
AKI for VIPCo - Sandokji.pptx
Ibrahim Sandokji
 
Pediatric Chronic Kidney Diseases.pptx
Pediatric Chronic Kidney Diseases.pptxPediatric Chronic Kidney Diseases.pptx
Pediatric Chronic Kidney Diseases.pptx
Ibrahim Sandokji
 
Pediatric Acute Kidney Injury.pptx
Pediatric Acute Kidney Injury.pptxPediatric Acute Kidney Injury.pptx
Pediatric Acute Kidney Injury.pptx
Ibrahim Sandokji
 
Nocturnal Enuresis in Children.pptx
Nocturnal Enuresis in Children.pptxNocturnal Enuresis in Children.pptx
Nocturnal Enuresis in Children.pptx
Ibrahim Sandokji
 
Urinary Tract Infections in Children.pptx
Urinary Tract Infections in Children.pptxUrinary Tract Infections in Children.pptx
Urinary Tract Infections in Children.pptx
Ibrahim Sandokji
 
Nephrotic & Nephritic Syndromes in Children.pptx
Nephrotic & Nephritic Syndromes in Children.pptxNephrotic & Nephritic Syndromes in Children.pptx
Nephrotic & Nephritic Syndromes in Children.pptx
Ibrahim Sandokji
 

More from Ibrahim Sandokji (20)

Journal Club. Joyce Zosyn and AKI in Children JASN 2019.pptx
Journal Club. Joyce Zosyn and AKI in Children JASN 2019.pptxJournal Club. Joyce Zosyn and AKI in Children JASN 2019.pptx
Journal Club. Joyce Zosyn and AKI in Children JASN 2019.pptx
 
Journal Club. Early prediction of pediatric acute kidney injury from the eme...
Journal Club. Early prediction of pediatric acute kidney injury  from the eme...Journal Club. Early prediction of pediatric acute kidney injury  from the eme...
Journal Club. Early prediction of pediatric acute kidney injury from the eme...
 
Journal Club. Native nephrectomy prior to pediatric kidney transplantation: b...
Journal Club. Native nephrectomy prior to pediatric kidney transplantation: b...Journal Club. Native nephrectomy prior to pediatric kidney transplantation: b...
Journal Club. Native nephrectomy prior to pediatric kidney transplantation: b...
 
Journal Club. Recurrence Of Nephrotic Syndrome Following Kidney Transplantat...
Journal Club. Recurrence Of Nephrotic Syndrome Following  Kidney Transplantat...Journal Club. Recurrence Of Nephrotic Syndrome Following  Kidney Transplantat...
Journal Club. Recurrence Of Nephrotic Syndrome Following Kidney Transplantat...
 
Lupus Nephritis - 2021.pptx
Lupus Nephritis - 2021.pptxLupus Nephritis - 2021.pptx
Lupus Nephritis - 2021.pptx
 
Sickle Cell Nephropathy.pptx
Sickle Cell Nephropathy.pptxSickle Cell Nephropathy.pptx
Sickle Cell Nephropathy.pptx
 
Serology in Renal Diseases.pptx
Serology in Renal Diseases.pptxSerology in Renal Diseases.pptx
Serology in Renal Diseases.pptx
 
RTA.pptx
RTA.pptxRTA.pptx
RTA.pptx
 
Renal Embryology.pptx
Renal Embryology.pptxRenal Embryology.pptx
Renal Embryology.pptx
 
Potassium Disorders.pptx
Potassium Disorders.pptxPotassium Disorders.pptx
Potassium Disorders.pptx
 
MPGN.pptx
MPGN.pptxMPGN.pptx
MPGN.pptx
 
Membranous.pptx
Membranous.pptxMembranous.pptx
Membranous.pptx
 
2017 AAP HTN Guidelines.pptx
2017 AAP HTN Guidelines.pptx2017 AAP HTN Guidelines.pptx
2017 AAP HTN Guidelines.pptx
 
Cystinosis.pptx
Cystinosis.pptxCystinosis.pptx
Cystinosis.pptx
 
AKI for VIPCo - Sandokji.pptx
AKI for VIPCo - Sandokji.pptxAKI for VIPCo - Sandokji.pptx
AKI for VIPCo - Sandokji.pptx
 
Pediatric Chronic Kidney Diseases.pptx
Pediatric Chronic Kidney Diseases.pptxPediatric Chronic Kidney Diseases.pptx
Pediatric Chronic Kidney Diseases.pptx
 
Pediatric Acute Kidney Injury.pptx
Pediatric Acute Kidney Injury.pptxPediatric Acute Kidney Injury.pptx
Pediatric Acute Kidney Injury.pptx
 
Nocturnal Enuresis in Children.pptx
Nocturnal Enuresis in Children.pptxNocturnal Enuresis in Children.pptx
Nocturnal Enuresis in Children.pptx
 
Urinary Tract Infections in Children.pptx
Urinary Tract Infections in Children.pptxUrinary Tract Infections in Children.pptx
Urinary Tract Infections in Children.pptx
 
Nephrotic & Nephritic Syndromes in Children.pptx
Nephrotic & Nephritic Syndromes in Children.pptxNephrotic & Nephritic Syndromes in Children.pptx
Nephrotic & Nephritic Syndromes in Children.pptx
 

Recently uploaded

Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 

Recently uploaded (20)

Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 

Nephrotoxins.pptx

  • 1. S L I D E 0 Nephrotoxins and drug interactions Ibrahim Sandokji
  • 2. S L I D E 1 15 y/o male presents with back pain and malaise. He took ibuprofen and naproxen last week. No fever. Normal urine output. Normal BPs. No edema. Serum creatinine 3.6 mg/dL. The most likely finding on urinalysis would be: a) 1+ heme, 1+ LE, >100 WBC/hpf b) Bland urine with trace protein c) Dysmorphic RBCs, RBC casts, heavy protein d) Muddy brown casts, debris
  • 3. S L I D E 2 ABP Content Specifications • Nephrotoxins and drug interactions: – Know common nephrotoxins, their mechanisms of nephrotoxicity, and their clinical manifestations – Know the natural history of kidney injury caused by common nephrotoxins – Recognize drugs that potentiate nephrotoxicity – Know the management of different types of nephrotoxicity • Nephrotoxic Injury Negated by Just-in-time Action (NINJA)
  • 4. S L I D E 3 Kidney Vulnerability • Final pathways for xenobiotics excretion (particularly, hydrophilic drugs) • Proximal tubular cells possess specific secretory pathways -> high concentrations during transcellular transport -> cytotoxicity • Large amount of energy consumption. Alterations of blood supply - > profound cellular damage • Large amount of oxygen requirement -> high susceptibility to oxidative stress • Several medications alter renal hemodynamics -> ischemic damage • Some drugs are highly concentrated in the tubular lumen and can crystallize -> obstructive nephropathy
  • 5. S L I D E 4 Natural History of Nephrotoxic-induced AKI • Usually non-oliguric AKI • Typically dose-dependent (except AIN which is idiosyncratic) and more likely to occur with nephrotoxin combinations • Urinalysis is often bland • Might see WBCs & possibly eosinophils in the urine • Recovery after removing offending agent(s)
  • 6. S L I D E 5
  • 7. S L I D E 6 Acyclovir • Nephrotoxicity can be seen in 17–35% of children receiving IV acyclovir. (Rao 2015) Mechanism of toxicity: • Rapidly excreted in the urine (both filtered and secreted) • Crystallization in tubular lumen -> obstructive nephropathy • Direct tubular toxicity • Transported by shared organic acid transporters with certain beta- lactam antibiotics (particularly ceftriaxone) -> increase nephrotoxicity risk
  • 8. S L I D E 7 Acyclovir • Prevention of nephrotoxicity: – Optimize hydration – Administer over 1–2 hours – Adjust dose if decreased renal function – Avoid concurrent nephrotoxic medication exposure
  • 9. S L I D E 8 Amphotericin B • AKI occurs in 49–65% of adult receiving amphotericin B Mechanism of toxicity: • Direct distal tubular toxicity: affect ergosterol in the epithelial cell membrane -> forms pores in the epithelial cell membrane • Renal vasoconstriction • Increased tubular membrane permeability lead to hypokalemia, hyponatremia, acidosis & hypomagnesemia • Risk factors: – Cumulative dose – Treatment duration – Dosing schedule – Dehydration – Concomitant diuretics or other nephrotoxic drugs – Impaired glomerular filtration at baseline
  • 10. S L I D E 9 Amphotericin B • Lipid formulations of amphotericin B (liposomal, lipid complex, colloidal dispersion): • A European multicenter prospective open-label study with 134 adults and 204 children with fever and neutropenia compared the use of liposomal and conventional amphotericin B: – Similar efficacy, defined as resolution of fever in 3 consecutive days & recovery of neutrophils – Nephrotoxicity (doubling of baseline creatinine) occurred in 3% of liposomal amphotericin, compared to 23% of conventional amphotericin B group (P<0.01) – Time to develop nephrotoxicity was longer in liposomal amphotericin than amphotericin B (P<0.01) and severe hypokalaemia was observed less frequently in liposomal amphotericin (P<0.01) Prentice 1997
  • 11. S L I D E 10 Aminoglycosides Mechanism of toxicity: • In the kidney, aminoglycosides exclusively accumulate in proximal tubular cells via endocytic pathways -> transported to the endosomal compartment -> accumulates in the lysosomes -> secretory pathway to the Golgi apparatus and ER • ER stress: disruption of normal protein folding -> accumulation of misfolded and unfolded proteins induces their aggregation and subsequent cytotoxicity -> acute tubular necrosis • Destabilize intracellular membranes -> redistribution of the drug throughout the cytosol -> acts on the mitochondria -> induce apoptosis • In the lysosomes, aminoglycosides bind to phospholipids -> inhibition of phospholipase activity -> phospholipid accumulation - > tubular cell death
  • 12. S L I D E 11 Aminoglycosides • Factors associated with increased risk of nephrotoxicity: – Drug dosage – Duration of administration – Dosing interval – Preexisting renal disease – Dehydration – Hepatic dysfunction – Sepsis – Concomitant nephrotoxic and diuretic drugs Patzer (2008) • Cochrane review of 13 RCT showed: • Once- and three-times-daily equally effective in CF pulmonary exacerbations • The percentage change in creatinine significantly favoured once- daily treatment in children, MD -8.20 (95% CI -15.32 to -1.08), but showed no difference in adults, MD 3.25 (95% CI -1.82 to 8.33). Smyth AR (2010)
  • 13. S L I D E 12 Vancomycin • Nephrotoxicity occurs in 12–43% of adults treated with vancomycin. (Rybak 2009) Mechanism of toxicity: • Proximal renal tubular cells are the main nephron segment impaired by vancomycin • Energy-dependent transport of vancomycin from the blood to the proximal tubular cells across the basolateral membrane • Exposure to high doses over long time -> oxidative stress and mitochondrial damage
  • 14. S L I D E 13 Vancomycin • Factors associated with increased risk of nephrotoxicity: – Drug dosage – Duration of administration – Preexisting renal disease Patzer (2008) – Critical illness – Concomitant nephrotoxic • A retrospective chart review in NICU • AKI occurred in 2.7% of patients (increase in SCr of at least 0.5 mg/L or an increase of at least 100% from lowest trough previously available) Bhargava (2017) Fit plot between vancomycin trough concentrations and post vancomycin creatinine. The plot depicts a positive co-relation between the two parameters
  • 15. S L I D E 14 Calcineurin Inhibitor (Cyclosporin A) • Acute toxicity (reversible): – Afferent arteriolar vasospasm – Renal hypoperfusion and decreased GFR – Reversible with decrease the dose or discontinuation • Tubular toxic effects: Renal cell apoptotic mechanisms of CyA-induced
  • 16. S L I D E 15 Calcineurin Inhibitor (Cyclosporin A) • CNI Nephropathy: – Proximal tubular injury -> tubular atrophy – Diffuse interstitial fibrosis or striped interstitial fibrosis – Arteriopathy: constrictive proliferation with mucoid thickening and arterial hyalinosis
  • 17. S L I D E 16 CNI Nephropathy (a) proximal tubular epithelial cell showing the fine isometric vacuoles; (b) typical striped fibrosis pattern (c) an afferent arteriole showing the characteristic nodular hyaline arteriosclerosis; (d) similar nodule in a non-afferent arteriole
  • 18. S L I D E 17 Calcineurin Inhibitor • Tacrolimus – Similar side effect profile – Less cosmetic effects • Gingival hyperplasia • Hirsutism – Less hyperlipidemia • In a Prospective study of 41 patients divided • Hirsutismus and gingival hyperplasia were seen in 10%, and 15% of CsA group, while it wasn’t observed at all in the Tac group • No difference in nephrotoxicity or hepatotoxicity (Ozan 2013)
  • 19. S L I D E 18 NSAIDs
  • 20. S L I D E 19 NSAIDs Medical Pharmacology, TMWeb, Tulane University
  • 21. S L I D E 20 NSAIDs • Case series of 7 children aged 13–17.5 years developed AKI after treatment with various NSAIDs – (6/7) used more than one kind of NSAID – 1 to 4 days between NSAID use and symptoms – Flank pain (4/7), abdominal pain (3/7), and vomiting (3/7) – All patients had nonoliguric AKI – Microscopic hematuria and proteinuria (5/7) patients – Biopsy done in three patients: • Mild interstitial inflammation in one patient • Normal in two patients – All patients were treated with intravenous fluids • One patient received corticosteroids – Renal function was completely normalized in all patients within 7–16 days Krause 2005
  • 22. S L I D E 21 Acute Interstitial Nephritis • Usually present with rise in sCr and non-specific symptoms • Nausea, vomiting, malaise, back/flank pain, or asymptomatic • Allergic-type symptoms like fevers, rash, peripheral eosinophilia • UA: WBC casts, hematuria, mild proteinuria, or bland urine • Non-Oliguria AKI, tubular dysfunction and even Fanconi syndrome • Treatment: – Discontinuation of offending agent – Rarely might need a biopsy if: • Unclear diagnosis • When considering steroid therapy • Or, if started steroids but no response in one week
  • 23. S L I D E 22 Singh AK, Colvin RB. N Engl J Med 2003;349:2055-2063. Acute Interstitial Nephritis
  • 24. S L I D E 23 White Blood Cell Casts Red Blood Cell Casts Hyaline Casts Muddy Brown Granular Casts Waxy Casts Fatty Casts
  • 25. S L I D E 24 Low power view of severe acute interstitial nephritis showing diffuse interstitial inflammatory infiltrate Inflammatory process predominantly in the interstitium. Insert shows a higher magnification, with arrows pointing to eosinophils in the interstitium
  • 26. S L I D E 25 Nephrotoxic Injury Negated by Just-in-time Action (NINJA) • Automated system using EHR data in patients with 3+ nephrotoxic medications or 3+ days of IV aminoglycoside exposure
  • 27. S L I D E 26 • 1,749 patients with 2,358 admissions were included. 575 individual AKI episodes were observed (47% stage 1, 33% stage 2, and 20% stage 3) • Nephrotoxic medication exposure rate decreased by 38% (from 11.63 to 7.24 patients/1000 patient days) Nephrotoxic Injury Negated by Just-in-time Action (NINJA)
  • 28. S L I D E 27 • AKI rates decreased by 64% (from 2.96 to 1.06 patients with AKI/1000 patient days) during the study period. Nephrotoxic Injury Negated by Just-in-time Action (NINJA)
  • 29. S L I D E 28 15 y/o male presents with back pain and malaise. He took ibuprofen and naproxen last week. No fever. Normal urine output. Normal BPs. No edema. Serum creatinine 3.6 mg/dL. The most likely finding on urinalysis would be: a) 1+ heme, 1+ LE, >100 WBC/hpf b) Bland urine with trace protein c) Dysmorphic RBCs, RBC casts, heavy protein d) Muddy brown casts, debris
  • 30. S L I D E 29 Summary
  • 31. S L I D E 30 References • Avner, et al. Pediatric Nephrology. 2016 • Bhargava, et al. The association between vancomycin trough concentrations and acute kidney injury in the neonatal intensive care unit. BMC Pediatr. 2017 Feb 11;17(1):50. • Ekmekçioğlu, et al. Comparison of tacrolimus with a cyclosporine microemulsion for immunosuppressive therapy in kidney transplantation. Turkish journal of urology. 2013;39(1):16-21. • Goldstein SL, Mottes T, Simpson K, Barclay C, Muething S, Haslam DB, Kirkendall ES. A sustained quality improvement program reduces nephrotoxic medication-associated acute kidney injury. Kidney Int. 2016 Jul;90(1):212-21 • Krause, et al. Acute renal failure, associated with non-steroidal anti-inflammatory drugs in healthy children. Pediatr Nephrol. 2005 Sep;20(9):1295-8. • Patzer L. Nephrotoxicity as a cause of acute kidney injury in children. Pediatr Nephrol. 2008;23(12):2159–73. • Prentice, et al. A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. Br J Haematol. 1997;98: 711–718 • Rao, et al. Intravenous acyclovir and renal dysfunction in children: a matched case control study. J Pediatr. 2015 Jun;166(6):1462-8. • Rybak, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2009;66(1):82–98. • Smyth, et al. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis. Cochrane Database Syst Rev. 2014;2. • Uijtendaal, et al. Once-daily versus multiple-daily gentamicin in infants and children. Ther Drug Monit. 2001;23 (5):506–13. • Vandecasteele, et al. Recent changes in vancomycin use in renal failure. Kidney Int. 2010;77(9):760–4.
  • 32. S L I D E 31 Extra Slides
  • 33. S L I D E 32 Classification of nephrotoxic medications Pathophysiology Drugs known to cause acute kidney injury Prerenal NSAIDs, ACE inhibitors, cyclosporine A (CyA), norepinephrine, AT2- receptor antagonists, diuretics, interleukins, cocaine, mitomycin C, tacrolimus, estrogen, quinine Acute tubular necrosis Antibiotics: aminoglycosides, cephalosporins, amphotericin B, rifampicin, vancomycin, foscarnet, pentamidine NSAIDs, glaphenin, contrast media, acetaminophen, CyA, cisplatinum, immunoglobulin, dextran, maltose, sucrose, mannitol, heavy metals Acute interstitial nephritis Antibiotics: ciprofloxacin, methicillin, penicillin G, ampicillin, cephalosporins, oxacillin, rifampicin NSAIDs, glaphenin, acetylsalicylic acid (ASA), fenoprofen, naproxen, phenylbutazone, piroxicam, tolmetin, zomepirac, contrast media, sulfonamides, thiazides, phenytoin, furosemide, allopurinol, cimetidine, omeprazole, phenindione Tubular obstruction Sulfonamides, methotrexate, methoxyflurane, glaphenin, triamterene, acyclovir, ethylene glycol, protease inhibitors Hypersensitivity angiitis Penicillin G, ampicillin, sulfonamides Thrombotic microangiopathy Mitomycin C, CyA, oral contraceptives

Editor's Notes

  1. Nephrotoxicity defined as a doubling from the patients baseline serum creatinine level
  2. Fas/Fas L pathway is a transmembrane signaling pathway. Upon activation -> apoptosis. Fas-associated protein with death domain (FADD)
  3. Hyaline Normal individuals Dehydration Heavy exercise Granular casts After sternous exercise Chronic renal diseases Acute tubular necrosis Waxy casts (renal failure casts) Severe chronic renal disease renal amyloidosis Fatty casts Tubular degeneration Nephrotic syndrome Hypothyroidism RBC Casts Pyelonephritis Glomerulonephritis Acute interstitial nephritis Lupus nephritis WBC Casts Glomerulonephritis
  4. Started in 2011 at the Cincinnati Children’s Hospital Medical Center (CCHMC) and now in use at >15 children’s hospitals throughout the US
  5. a)UTI C)GN D)ATN